Literature DB >> 6023988

Gentamicin and colistin in chronic purulent bronchial infections.

A Pines, H Raafat, K Plucinski.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 6023988      PMCID： PMC1842456          DOI： 10.1136/bmj.2.5551.543

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  8 in total

1.  GENTAMICIN IN GRAM-NEGATIVE URINARY AND PULMONARY INFECTIONS.

Authors:  R G BRAYTON; D B LOURIA
Journal:  Arch Intern Med       Date:  1964-08

2.  GENTAMICIN: ACTIVITY IN VITRO AND OBSERVATIONS IN 26 PATIENTS.

Authors:  J O KLEIN; T C EICKHOFF; M FINLAND
Journal:  Am J Med Sci       Date:  1964-11       Impact factor: 2.378

3.  GENTAMICIN SULFATE IN THE TREATMENT OF PSEUDOMONAS SEPSIS IN BURNS.

Authors:  H H STONE; J D MARTIN; W E HUGER; L KOLB
Journal:  Surg Gynecol Obstet       Date:  1965-02

4.  CHLORAMPHENICOL ANALOGUES IN THE INTRABRONCHIAL TREATMENT OF SEVERE CHRONIC CHEST INFECTIONS.

Authors:  A PINES; R S BUNDI; J S GREENFIELD; K PLUCINSKI
Journal:  Br J Dis Chest       Date:  1965-04

5.  Colimycin in chronic purulent respiratory disorders.

Authors:  A PINES; T J LYDON; K PLUCINSKI; H BARKLEY
Journal:  Practitioner       Date:  1963-04

6.  The bacteriology of chronic bronchitis.

Authors:  J R MAY
Journal:  Lancet       Date:  1953-09-12       Impact factor: 79.321

7.  An analysis of factors predisposing to gram-negative bacillary necrotizing pneumonia.

Authors:  A K Pierce; E B Edmonson; G McGee; J Ketchersid; R G Loudon; J P Sanford
Journal:  Am Rev Respir Dis       Date:  1966-09

8.  Activity of gentamicin against Pseudomonas and hospital Staphylococci.

Authors:  M Barber; P M Waterworth
Journal:  Br Med J       Date:  1966-01-22
  8 in total
  10 in total

Review 1.  Aerosolised antibacterials for the prevention and treatment of hospital-acquired pneumonia.

Authors:  G Christopher Wood; Joseph M Swanson
Journal:  Drugs       Date:  2007       Impact factor: 9.546

2.  Gentamicin.

Authors:  J F Macdonald
Journal:  Can Med Assoc J       Date:  1967-10-07       Impact factor: 8.262

Review 3.  Inhaled Antibiotics for Gram-Negative Respiratory Infections.

Authors:  Eric Wenzler; Dustin R Fraidenburg; Tonya Scardina; Larry H Danziger
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

4.  Intravenous colistin sulphomethate in acute respiratory exacerbations in adult patients with cystic fibrosis.

Authors:  S P Conway; M N Pond; A Watson; C Etherington; H L Robey; M H Goldman
Journal:  Thorax       Date:  1997-11       Impact factor: 9.139

Review 5.  Clinical pharmacokinetics of aminoglycoside antibiotics.

Authors:  J C Pechere; R Dugal
Journal:  Clin Pharmacokinet       Date:  1979 May-Jun       Impact factor: 6.447

6.  The differential attachment of antibiotics to glycoprotein and blood lymphocytes.

Authors:  B A Saggers; D Lawson
Journal:  J Clin Pathol       Date:  1970-04       Impact factor: 3.411

7.  Gentamicin.

Authors: 
Journal:  Can Med Assoc J       Date:  1967-07-15       Impact factor: 8.262

Review 8.  Inhaled therapeutics for prevention and treatment of pneumonia.

Authors:  Amar Safdar; Samuel A Shelburne; Scott E Evans; Burton F Dickey
Journal:  Expert Opin Drug Saf       Date:  2009-07       Impact factor: 4.250

9.  Treatment of severe pseudomonas infections of the bronchi.

Authors:  A Pines; H Raafat; G M Siddiqui; J S Greenfield
Journal:  Br Med J       Date:  1970-03-14

10.  Carbenicillin: activity in vitro and absorption and excretion in normal young men.

Authors:  C B Smith; M Finland
Journal:  Appl Microbiol       Date:  1968-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.